Table 3.
The frequency of various patterns of antibiotic use in C. perfringens-positive patients with AAD.
| Patterns of antibiotic use | AAD group (n = 68) |
|---|---|
| Ceftriaxone | 3 (4.4) |
| Ciprofloxacin | 3 (4.4) |
| Metronidazole | 23 (33.6) |
| Meropenem | 2 (2.9) |
| Chloramphenicol | 1 (1.5) |
| Imipenem | 2 (2.9) |
| Tinidazole | 1 (1.5) |
| Metronidazole + Vancomycin | 10 (14.6) |
| Metronidazole + Ciprofloxacin | 6 (8.8) |
| Metronidazole + Imipenem | 1 (1.5) |
| Metronidazole + Ceftriaxone | 1 (1.5) |
| Ciprofloxacin + Amikacin | 1 (1.5) |
| Ciprofloxacin + Ceftazidime | 1 (1.5) |
| Ciprofloxacin + Ceftriaxone | 1 (1.5) |
| Ciprofloxacin + Chloramphenicol | 1 (1.5) |
| Ciprofloxacin + Ceftriaxone | 1 (1.5) |
| Ciprofloxacin + Trimethoprim-Sulfamethoxazole | 1 (1.5) |
| Ciprofloxacin + Ceftazidime + Azithromycin | 1 (1.5) |
| Ciprofloxacin + Meropenem + Trimethoprim-Sulfamethoxazole | 1 (1.5) |
| Vancomycin + Ciprofloxacin | 2 (2.9) |
| Vancomycin + Imipenem | 1 (1.5) |
| Vancomycin + Meropenem | 1 (1.5) |
| Vancomycin + Amphotericin B | 1 (1.5) |
| Azithromycin + Cefixime | 1 (1.5) |
| Azithromycin + Cefixime + Metronidazole | 1 (1.5) |
AAD, antibiotic-associated diarrhea.